A systematic review of the diagnostic accuracy of volatile organic compounds in airway diseases and their relation to markers of type-2 inflammation

Wadah Ibrahim, Sushiladevi Natarajan, Michael Wilde, Rebecca Cordell, Paul S. Monks, Neil Greening, Christopher E. Brightling, Rachael Evans, Salman Siddiqui

Source: ERJ Open Res, 7 (3) 00030-2021; 10.1183/23120541.00030-2021

Journal Issue: July

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Wadah Ibrahim, Sushiladevi Natarajan, Michael Wilde, Rebecca Cordell, Paul S. Monks, Neil Greening, Christopher E. Brightling, Rachael Evans, Salman Siddiqui. A systematic review of the diagnostic accuracy of volatile organic compounds in airway diseases and their relation to markers of type-2 inflammation. ERJ Open Res, 7 (3) 00030-2021; 10.1183/23120541.00030-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Volatile organic compounds and risk of asthma and allergy: a systematic review Source: Eur Respir Rev 2015; 24: 92-101 Year: 2015
Interpretation of exhaled volatile organic compounds Source: Eur Respir Monogr 2010; 49: 115-129 Year: 2010
Volatile organic compounds may provide a new and promising tool for diagnosing interstitial lung diseases Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015
Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Overview and history of different ways of assessing and monitoring inflammatory airway diseases Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017
Usefulness of physiological tests of small airways function in diagnosing asthma: a systematic review Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020
Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort Source: Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020 Year: 2021
Limited clinical value of exhaled volatile organic compound measurements in childhood asthma Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018 Year: 2018
Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017 Year: 2018
Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Comparison of exhaled biomarkers to other markers of airway diseases Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker? Source: International Congress 2016 – The future of lung function is beginning now Year: 2016